Hepatitis A virus and B virus combined vaccine (Novartis)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHepatitis A virus and B virus combined vaccine (Novartis)

Drug Alias Namecombined inactivated hepatitis A plus recombinant hepatitis B vaccinecombined hepatitis A virus and B virus vaccineinactivated HAV + recombinant HBV vaccineHAV/HBV vaccine

ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHepatitis AHepatitis B

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNovartis Pharma Ag

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNovartis Pharma Ag

Active IndicationsN/A

Inactive IndicationsHepatitis AHepatitis B

Other Information

ATC CodeN/A